ABVC
NASDAQ
US
ABVC BioPharma, Inc. - Common Stock
$1.09
▲ +$0.01
(+0.93%)
Vol 55K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$51.8M
ROE
-64.1%
Margin
-127.5%
D/E
8.52
Beta
0.20
52W
$0–$5
Wall Street Consensus
6 analysts · Oct 20230
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2025 | — | $-0.06 | — |
| Jun 2023 | $-0.06 | $-0.68 | $-0.62 |
| Mar 2023 | $-0.51 | $-0.60 | $-0.09 |
| Dec 2022 | $-1.53 | $-1.50 | +$0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $2K | — | — | — | -$796K |
| Net Income | — | $229K | -$842K | -$2.3M | -$2.0M | -$3.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -55.6% | -55.6% | -55.6% | -55.6% | -64.1% | -64.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -962.1% | -948.5% | -948.5% | -127.5% | -127.5% |
| Gross Margin | — | 99.8% | 99.8% | 99.8% | 99.8% | 99.8% |
| D/E Ratio | 16.06 | 16.06 | 16.06 | 16.06 | 8.52 | 8.52 |
| Current Ratio | 0.42 | 0.42 | 0.42 | 0.42 | 0.63 | 0.63 |
Key Ratios
ROA (TTM)
-27.5%
P/S (TTM)
64.87
P/B
6.2
EPS (TTM)
$-0.22
CF/Share
$-3.45
Rev Growth 3Y
+12.3%
52W High
$5.48
52W Low
$0.40
$0.40
52-Week Range
$5.48
Financial Health
Free Cash Flow
-$1.4M
Net Debt
$2.8M
Cash
$681K
Total Debt
$3.5M
As of Dec 31, 2025
How does ABVC compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ABVC valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
64.9
▲
405%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
6.2
▲
154%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ABVC profitability vs Biotechnology peers
ROE
-64.1%
▲
5%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-127.5%
▲
56%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
99.9%
▲
27%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-27.5%
▲
41%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
ABVC financial health vs Biotechnology peers
D/E ratio
8.5
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.6
▼
86%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.2
▼
80%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ABVC fundamentals radar
ABVC
Peer median
Industry
ABVC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ABVC vs peers: key metrics
Top Holders
Top 5: 2.89%Vanguard Group Inc
1.13%
$288K
Geode Capital Management, L…
0.80%
$202K
Renaissance Technologies, L…
0.45%
$114K
State Street Corporation
0.29%
$73K
Blackrock Inc.
0.22%
$56K
As of Dec 31, 2025
Latest News
No related news yet